Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Marmor

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 1, 1993
Interferon-associated retinopathyD R Guyer, J Tiedeman, L A Yannuzzi, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1987
Nonrandom development of immunologic abnormalities after infection with human immunodeficiency virus: implications for immunologic classification of the diseaseS Zolla-Pazner, D C Des Jarlais, S R Friedman, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 7, 1998
"Why I am not infected with HIV": implications for long-term HIV risk reduction and HIV vaccine trialsD C Des Jarlais, S Vanichseni, M Marmor, et al.
NIDA Research Monograph|January 1, 1986
A stage model of HTLV-III LAV infection in intravenous drug usersD C Des Jarlais, S R Friedman, T J Spira, et al.
The Journal of Infectious Diseases|December 7, 2000
Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus loadC L Celum, S P Buchbinder, D Donnell, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
National AIDS incidence trends and the extent of zidovudine therapy in selected demographic and transmission groupsP S Rosenberg, M H Gail, L K Schrager, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|May 4, 1999
Correlates of condom failure in a sexually active cohort of men who have sex with menE Stone, P Heagerty, E Vittinghoff, et al.
American Journal of Public Health|December 8, 1998
Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996D C Des Jarlais, T Perlis, S R Friedman, et al.
American Journal of Epidemiology|April 3, 2001
Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness StudyG R Seage, S E Holte, D Metzger, et al.
The Journal of Infectious Diseases|April 11, 2001
Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteersR B Belshe, C Stevens, G J Gorse, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 1, 1993
Interferon-associated retinopathyD R Guyer, J Tiedeman, L A Yannuzzi, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1987
Nonrandom development of immunologic abnormalities after infection with human immunodeficiency virus: implications for immunologic classification of the diseaseS Zolla-Pazner, D C Des Jarlais, S R Friedman, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 7, 1998
"Why I am not infected with HIV": implications for long-term HIV risk reduction and HIV vaccine trialsD C Des Jarlais, S Vanichseni, M Marmor, et al.
NIDA Research Monograph|January 1, 1986
A stage model of HTLV-III LAV infection in intravenous drug usersD C Des Jarlais, S R Friedman, T J Spira, et al.
The Journal of Infectious Diseases|December 7, 2000
Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus loadC L Celum, S P Buchbinder, D Donnell, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
National AIDS incidence trends and the extent of zidovudine therapy in selected demographic and transmission groupsP S Rosenberg, M H Gail, L K Schrager, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|May 4, 1999
Correlates of condom failure in a sexually active cohort of men who have sex with menE Stone, P Heagerty, E Vittinghoff, et al.
American Journal of Public Health|December 8, 1998
Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996D C Des Jarlais, T Perlis, S R Friedman, et al.
American Journal of Epidemiology|April 3, 2001
Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness StudyG R Seage, S E Holte, D Metzger, et al.
The Journal of Infectious Diseases|April 11, 2001
Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteersR B Belshe, C Stevens, G J Gorse, et al.
Pageof 11